Adia Nutrition (OTCQB: ADIA) reporting fiscal 2025 results and strategic shift to regenerative medicine. Income rose to $700,508 from $6,380 in 2024, with a gross profit of $191,670. The company recorded an operating loss of $366,492 and a net loss of $395,464 and expressed doubts about the concern. Adia achieved … Read more
By 2024, there will be more mental health patients stuck waiting in hospital emergency departments than in 2022. But Massachusetts still has some of the longest waits in the nation, and behavioral health patients with unique needs — such as the elderly, pregnant women, or children with autism — too often can’t get the right … Read more
Dublin, March 27, 2026 (GLOBE NEWSWIRE) — The “Clinical Nutrition for Cancer Treatment Market Report 2026” has been added to the ResearchAndMarkets.com’s offer. The clinical nutrition for cancer treatment market has experienced substantial growth, with the market size increasing from $5.16 billion in 2025 to $5.42 billion in 2026, representing a compound annual growth rate … Read more
Clearmind Medicine (Nasdaq: CMND) Filed a patent application in India on March 27, 2026 for the next generation, non-hallucinogenic neuroplastogen-derived compounds targeting mental health disorders and addiction. The filing, with the Indian Patent Office, expands the company’s global intellectual property portfolio and forms an exclusive worldwide license agreement with Yissumseeking … Read more